Table 2.
Baseline and disease characteristics for randomized, evaluable patients
| Characteristic | Arm A (cetuximab alone) | Arm B (cetuximab + pemetrexed) |
|---|---|---|
| |
N = 20 |
N = 23 |
|
Age (years) |
|
|
| Median |
62 |
55 |
| Range |
(36–76) |
(45–75) |
|
Sex: No. (%) |
|
|
| Men |
14 (70) |
13 (57) |
| Women |
6 (30) |
10 (43) |
|
Ethnicity: No. (%) |
|
|
| White |
13 (65) |
17 (74) |
| African-American |
7 (35) |
5 (22) |
| Asian |
0 (0) |
1 (4) |
|
Smoking history: No. (%) |
|
|
| Current |
7 (35) |
6 (26) |
| Past |
11 (55) |
13 (57) |
| Never |
2 (10) |
2 (9) |
| Unknown |
0 (0) |
2 (9) |
|
Histology: No. (%) |
|
|
| Unspecified |
7 (35) |
9 (39) |
| Squamous |
6 (30) |
8 (35) |
| Adenocarcinoma | 7 (35) | 6 (26) |